Virios Therapeutics Inc expected to post a loss of 15 cents a share - Earnings Preview

Dogwood Therapeutics

10/03/2023 15:03

* Virios Therapeutics Inc  VIRI.OQ   VIRI.O  is expected
to show
no change in quarterly revenue when it reports  results on March
14. 
    * 
    * ​Refinitiv's mean analyst estimate for Virios Therapeutics
Inc
is for a loss of 15 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Virios
Therapeutics Inc is $2​, above​ its last closing price of $0.34.
​​​

This summary was machine generated March 10 at 15:03 GMT.  All
figures in US dollars  unless otherwise stated